National Institute of Mental Health and Neuro Sciences, India   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Bangalore India (1847)

Organization Overview

First Clinical Trial
2003
NCT00340379
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Dhritiman Chakrabarti | National Institute of Mental Health and Neuroscience | National Institute of Mental Health and Neuro Sciences, Bangalore, India | National Institute of Mental Health and Neuro Sciences, India

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Agnosia (Phase 4)

Bipolar Disorder (Phase 3)

Compulsive Personality Disorder (Phase 4)

Depression (Phase 3)

Disease (Phase 3)

Encephalitis (Phase 4)

Encephalitis, Japanese (Phase 4)

Mental Disorders (Phase 3)

Mood Disorders (Phase 3)

Obsessive-Compulsive Disorder (Phase 4)

Parkinson Disease (Phase 3)

Psychotic Disorders (Phase 3)

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 15